Medtronic has led a $37.0M Series C round for CoreMap, a company developing diagnostic technology aimed at personalizing treatment for atrial fibrillation. The investment underscores a push toward patient-specific approaches in electrophysiology, where the startup argues that a one-size-fits-all model falls short for the 33 million people affected by the condition.
















%20Ltd.png&w=3840&q=75)
